Form 485BXT ALLIANZ LIFE INSURANCE
Tweet
Share
E-mail
Index Advantage+, 485BXT
Filed on August 26, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM N-4
File Nos. 333-268962; 811-05618
|
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
|
|
|
Pre-Effective Amendment No.
|
|
|
Post-Effective Amendment No. 16
|
[X]
|
|
and/or
|
|
|
REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940
|
|
|
Amendment No. 695
|
[X]
|
|
(Check appropriate box or boxes.)
|
|
|
ALLIANZ LIFE VARIABLE ACCOUNT B
|
|
|
(Exact Name of Registered Separate Account)
|
|
|
ALLIANZ LIFE INSURANCE COMPANY OF NORTH AMERICA
|
|
|
(Name of Insurance Company)
|
|
File No. 333-268864
|
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
|
|
|
Pre-Effective Amendment No.
|
|
|
Post-Effective Amendment No. 12
|
[X]
|
|
(Check appropriate box or boxes.)
|
|
|
ALLIANZ LIFE INSURANCE COMPANY OF NORTH AMERICA
|
|
|
(Name of Insurance Company)
|
|
|
5701 Golden Hills Drive, Minneapolis, MN 55416-1297
|
|
(Address of Insurance Company’s Principal Executive Offices) (Zip Code)
|
|
(763) 582-6089
|
|
(Insurance Company’s Telephone Number, including Area Code)
|
|
Doug Hodgson, Senior Counsel, Associate General Counsel
|
|
Allianz Life Insurance Company of North America
|
|
5701 Golden Hills Drive
|
|
Minneapolis, MN 55416-1297
|
|
(Name and Address of Agent for Service)
|
Approximate Date of Proposed Public Offering: Continuously on and after the effective date of each Registration Statement.
|
It is proposed that this filing will become effective (check the appropriate box):
|
|
|
immediately upon filing pursuant to paragraph (b)
|
|
|
X
|
on September 25, 2026, pursuant to paragraph (b)
|
|
60 days after filing pursuant to paragraph (a)(1)
|
|
|
on (date) pursuant to paragraph (a)(1) of rule 485 under the Securities Act of 1933 (“Securities Act”).
|
|
|
If appropriate, check the following:
|
|
|
X
|
This post-effective amendment designates a new effective date for a previously filed post-effective amendment.
|
|
Check each box that appropriately characterizes the Registrant:
|
|
|
New Registrant (as applicable, a Registered Separate Account or Insurance Company that has not filed a Securities Act registration statement or amendment thereto within 3 years preceding this filing)
|
|
|
Emerging Growth Company (as defined by Rule 12b-2 under the Securities Exchange Act of 1934 (“Exchange Act”))
|
|
|
If an Emerging Growth Company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial account standards provided pursuant to Section 7(a)(2)(B) of the Securities Act
|
|
|
X
|
Insurance Company relying on Rule 12h-7 under the Exchange Act
|
|
Smaller reporting company (as defined by Rule 12b-2 under the Exchange Act)
|
Parts A, B and C were filed in Registrant’s Post-Effective Amendment Nos. 15 (File No. 333-268962) and 11 (File No. 333-268864) on June 29, 2026 and are incorporated by reference.
Pursuant to Rule 485(b)(1)(iii) of the Securities Act of 1933, the sole purpose of this Post-Effective Amendment No. 16 (File No. 333-268962) and 12 (File No. 333-268864) is to delay the effective date of Post-Effective Amendment Nos. 15 (File No. 333-268962) and 11 (File No. 333-268864), which were filed on June 29, 2026. The Post-Effective Amendment does not amend or delete the currently effective Prospectus, Supplements or Statement of Additional Information or any other part of the Registration Statement except as specifically noted herein. We will make a filing pursuant to Rule 485(b) at a future date which incorporates all staff comments and any required missing information or items.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registered Separate Account has duly caused this registration statement to be signed on its behalf by the undersigned, duly authorized, in the City of Minneapolis and State of Minnesota, on this 26th day of August, 2026.
|
|
ALLIANZ LIFE VARIABLE ACCOUNT B
(Registered Separate Account)
|
|
|
|
By:
|
/s/ Jasmine M. Jirele*
|
|
|
|
Jasmine M. Jirele
|
|
|
|
President and Chief Executive Officer
|
|
|
ALLIANZ LIFE INSURANCE COMPANY OF NORTH AMERICA
(Insurance Company)
|
|
|
|
By:
|
/s/ Jasmine M. Jirele*
|
|
|
|
Jasmine M. Jirele
|
|
|
|
President and Chief Executive Officer
|
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ Jasmine M. Jirele*
|
|
Director, President & Chief Executive Officer (principal executive officer)
|
|
August 26, 2026
|
|
Jasmine M. Jirele
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Andreas G. Wimmer*
|
|
Director and Board Chair
|
|
August 26, 2026
|
|
Andreas G. Wimmer
|
|
|
|
|
|
|
|
|
|
|
|
/s/ William E. Gaumond*
|
|
Director, Executive Vice President, Chief Financial Officer and Treasurer (principal financial officer and principal accounting officer)
|
|
August 26, 2026
|
|
William E. Gaumond
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Howard E. Woolley*
|
|
Director
|
|
August 26, 2026
|
|
Howard E. Woolley
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Udo Frank*
|
|
Director
|
|
August 26, 2026
|
|
Udo Frank
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Kevin E. Walker*
|
|
Director
|
|
August 26, 2026
|
|
Kevin E. Walker
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Walter R. White*
|
|
Director
|
|
August 26, 2026
|
|
Walter R. White
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Lauren Kathryn Day*
|
|
Director
|
|
August 26, 2026
|
|
Lauren Kathryn Day
|
|
|
|
*By Power of Attorney, dated July 2025, incorporated by reference as EX-99.27(p) from Post-Effective Amendment No. 16 to Allianz Life Insurance Company’s Form N-4 (File Nos. 333-264349) electronically filed on July 22, 2025.
|
*By:
|
/s/ Doug Hodgson
|
|
|
Doug Hodgson
|
|
|
Senior Counsel, Associate General Counsel
Pursuant to Power of Attorney
|
File Nos. 333-268962; 811-05618
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, duly authorized, in the City of Minneapolis and State of Minnesota, on this 26th day of August, 2026.
|
|
ALLIANZ LIFE INSURANCE COMPANY OF NORTH AMERICA
(Insurance Company – Registrant)
|
|
|
|
By:
|
/s/ Jasmine M. Jirele*
|
|
|
|
Jasmine M. Jirele
|
|
|
|
President and Chief Executive Officer
|
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ Jasmine M. Jirele*
|
|
Director, President & Chief Executive Officer (principal executive officer)
|
|
August 26, 2026
|
|
Jasmine M. Jirele
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Andreas G. Wimmer*
|
|
Director and Board Chair
|
|
August 26, 2026
|
|
Andreas G. Wimmer
|
|
|
|
|
|
|
|
|
|
|
|
/s/ William E. Gaumond*
|
|
Director, Executive Vice President, Chief Financial Officer and Treasurer (principal financial officer and principal accounting officer)
|
|
August 26, 2026
|
|
William E. Gaumond
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Howard E. Woolley*
|
|
Director
|
|
August 26, 2026
|
|
Howard E. Woolley
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Udo Frank*
|
|
Director
|
|
August 26, 2026
|
|
Udo Frank
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Kevin E. Walker*
|
|
Director
|
|
August 26, 2026
|
|
Kevin E. Walker
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Walter R. White*
|
|
Director
|
|
August 26, 2026
|
|
Walter R. White
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Lauren Kathryn Day*
|
|
Director
|
|
August 26, 2026
|
|
Lauren Kathryn Day
|
|
|
|
*By Power of Attorney, dated July 2025, incorporated by reference as EX-99.27(p) from Post-Effective Amendment No. 16 to Allianz Life Insurance Company’s Form N-4 (File Nos. 333-264349) electronically filed on July 22, 2025.
|
*By:
|
/s/ Doug Hodgson
|
|
|
Doug Hodgson
|
|
|
Senior Counsel, Associate General Counsel
Pursuant to Power of Attorney
|
File No. 333-268864
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IC Group Reports Q2 2026 Results; Revenue Up 26% Year-over-Year, Driven By 97% Organic Growth of Annual Recurring Revenue
- Haivision to Announce Third Quarter Fiscal 2026 Financial Results on September 9, 2026
- Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
